It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

dementia

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab

Business / Financial Markets Jan 10, 2023

Eisai shares jump after FDA approves Alzheimer’s drug lecanemab

by Kanoko Matsuyama

The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.

Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough

Business / Corporate Dec 28, 2022

Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough

by Kanoko Matsuyama

Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer’s biomarkers in blood tests.

Japan approves blood test to detect Alzheimer’s

National / Science & Health Dec 22, 2022

Japan approves blood test to detect Alzheimer’s

Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon. Sysmex’s diagnostic product that measures amyloid beta in the ...

Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge

Business Nov 30, 2022

Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge

by Robert Langreth

The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.

Eisai and Biogen plunge after report of second death in Alzheimer’s trial

Business / Financial Markets Nov 29, 2022

Eisai and Biogen plunge after report of second death in Alzheimer’s trial

by Naomi Kresge

The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.

New Alzheimer's drug from Biogen and Eisai is just the beginning

Commentary / World Oct 4, 2022

New Alzheimer's drug from Biogen and Eisai is just the beginning

by Lisa Jarvis

A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.

Eisai drug's trial success raises hope for Alzheimer's prevention

World / Science & Health | ANALYSIS Sep 30, 2022

Eisai drug's trial success raises hope for Alzheimer's prevention

by Julie Steenhuysen

Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.

Aichi cafe gives joy to older people with dementia and their families

National / Social Issues Sep 29, 2022

Aichi cafe gives joy to older people with dementia and their families

Anki Cafe gives people a comfortable place in which to socialize and interact with children who help out there.

Alzheimer’s progression slowed by drug in major trial

National / Science & Health Sep 28, 2022

Alzheimer’s progression slowed by drug in major trial

by Robert Langreth

The drug slowed cognitive decline in people with early Alzheimer’s by 27% over 18 months when compared with a placebo using a common rating scale.

Eisai says Alzheimer’s drug will get priority review in U.S.

Business / Corporate Jul 6, 2022

Eisai says Alzheimer’s drug will get priority review in U.S.

by Robert Langreth and Kanoko Matsuyama

Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.

Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug

Business Apr 9, 2022

Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug

The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.

Tokyo care center operator helps elderly people with dementia find fulfillment through work

National / Science & Health Mar 25, 2022

Tokyo care center operator helps elderly people with dementia find fulfillment through work

Takayuki Maeda was once treated as an anomaly among social workers, but now government rules and standards are catching up.

« 1 2 3 … 13 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times